- Home
- GNLX vs GGZ Comparison
GNLX vs GGZ Comparison
Compare GNLX & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.66
Company Overview
Basic Information| Metric | GNLX | GGZ |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.8M | 129.8M |
| IPO Year | 2022 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GNLX | GGZ |
|---|---|---|
| Price | $2.66 | $15.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $19.75 | N/A |
| AVG Volume (30 Days) | ★ 150.4K | 7.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.10 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $10.50 |
| 52 Week High | $8.54 | $16.80 |
Technical Indicators
Market Signals| Indicator | GNLX | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.94 | 34.08 |
| Support Level | $2.54 | $13.36 |
| Resistance Level | $2.80 | $16.75 |
| Average True Range (ATR) | 0.17 | 0.23 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 17.20 | 9.06 |
Price Performance
Historical Comparison GNLX
GGZ
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.